Long-Acting Beta-Agonist Monotherapy Among Children and Adults With Asthma
Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education.
Geographic Variation of Asthma Quality Measures Within and Between Health Plans